FDA Panel To Influenza Home MedKit Sponsors: Get Real
This article was originally published in The Tan Sheet
Executive Summary
Roche begins label comprehension studies this month to support development of aTamiflu home MedKit for the treatment or prophylaxis of pandemic influenza virus, under an initiative driven by the Department of Health and Human Services
You may also be interested in...
Sanofi Licenses OTC Tamiflu From Roche To Attempt First US Flu Treatment Switch
Sanofi consumer health chief Alan Main says with the US the largest OTC drug market, a successful switch for Tamiflu, marketed in the US by Roche subsidiary Genentech, would support the firm's global strategy for expanding cough and cold remedy sales.
Experts Support Statin, Triptan, Sleep Aid Switches In New Paradigm
The American Society of Health-System Pharmacists has opposed allowing OTC sales of statins, but would support a switch made with conditions of safe use required. A Philadelphia College of Pharmacy professor argues that patients are better served by obtaining pharmaceuticals from health care professionals than using “un-standardized” dietary supplements
Experts Support Statin, Triptan, Sleep Aid Switches In New Paradigm
The American Society of Health-System Pharmacists has opposed allowing OTC sales of statins, but would support a switch made with conditions of safe use required. A Philadelphia College of Pharmacy professor argues that patients are better served by obtaining pharmaceuticals from health care professionals than using “un-standardized” dietary supplements